Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 職業醫學與工業衛生研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74821
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor楊孝友(Hsiao-Yu Yang)
dc.contributor.authorChian Zengen
dc.contributor.author曾千zh_TW
dc.date.accessioned2021-06-17T09:08:14Z-
dc.date.available2025-03-12
dc.date.copyright2020-03-12
dc.date.issued2019
dc.date.submitted2019-11-18
dc.identifier.citation1. World Health Organization : Cancer. 2017. (Accessed accessed on: 26 October 2017, 2017, at Available online: http://www.who.int/mediacentre/factsheets/fs297/en/.)
2. Huang C-H, Zeng C, Wang Y-C, et al. A Study of Diagnostic Accuracy Using a Chemical Sensor Array and a Machine Learning Technique to Detect Lung Cancer. Sensors 2018;18:2845.
3. Loft S, Poulsen HE. Cancer risk and oxidative DNA damage in man. J Mol Med (Berl) 1996;74:297-312.
4. Kneepkens CF, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radical Biology and Medicine 1994;17:127-60.
5. Hakim M, Broza YY, Barash O, et al. Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev 2012;112:5949-66.
6. Lourenco C, Turner C. Breath analysis in disease diagnosis: methodological considerations and applications. Metabolites 2014;4:465-98.
7. Wiener-Kronish JP, Broaddus VC. Interrelationship of pleural and pulmonary interstitial liquid. Annu Rev Physiol 1993;55:209-26.
8. Lai-Fook SJ. Pleural mechanics and fluid exchange. Physiol Rev 2004;84:385-410.
9. Yu CJ, Wang CL, Wang CI, et al. Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology. J Proteome Res 2011;10:4671-82.
10. Rodriguez-Pineiro AM, Blanco-Prieto S, Sanchez-Otero N, Rodriguez-Berrocal FJ, de la Cadena MP. On the identification of biomarkers for non-small cell lung cancer in serum and pleural effusion. J Proteomics 2010;73:1511-22.
11. Patti GJ, Yanes O, Siuzdak G. Innovation: Metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012;13:263-9.
12. Alonso A, Marsal S, Julia A. Analytical methods in untargeted metabolomics: state of the art in 2015. Front Bioeng Biotechnol 2015;3:23.
13. Vinayavekhin N, Saghatelian A. Untargeted metabolomics. Curr Protoc Mol Biol 2010;Chapter 30:Unit 30 1 1-24.
14. Smolinska A, Hauschild AC, Fijten RR, Dallinga JW, Baumbach J, van Schooten FJ. Current breathomics--a review on data pre-processing techniques and machine learning in metabolomics breath analysis. J Breath Res 2014;8:027105.
15. Cleaning Glass or Quartz Sample Containers Trainstrument Instruments. at http://www.tainstruments.com/pdf/literature/TN060_Glass_Cleaning.pdf.)
16. Liu H, Wang H, Li C, Wang L, Pan Z, Wang L. Investigation of volatile organic metabolites in lung cancer pleural effusions by solid-phase microextraction and gas chromatography/mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2014;945-946:53-9.
17. Risticevic S, Lord H, Gorecki T, Arthur CL, Pawliszyn J. Protocol for solid-phase microextraction method development. Nat Protoc 2010;5:122-39.
18. Agency USEP. Compendium of methods for the determination of toxic organic compounds in ambient air: Center for Environmental Research Information, National Risk Management Research Laboratory, Office of Research and Development, US Environmental Protection Agency; 1999.
19. Pluskal T, Castillo S, Villar-Briones A, Oresic M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 2010;11:395.
20. Timischl B, Dettmer K, Kaspar H, Thieme M, Oefner PJ. Development of a quantitative, validated capillary electrophoresis-time of flight-mass spectrometry method with integrated high-confidence analyte identification for metabolomics. Electrophoresis 2008;29:2203-14.
21. Samanipour S, Reid MJ, Thomas KV. Statistical Variable Selection: An Alternative Prioritization Strategy during the Nontarget Analysis of LC-HR-MS Data. Anal Chem 2017;89:5585-91.
22. Hu M, Krauss M, Brack W, Schulze T. Optimization of LC-Orbitrap-HRMS acquisition and MZmine 2 data processing for nontarget screening of environmental samples using design of experiments. Anal Bioanal Chem 2016;408:7905-15.
23. Jiang Y, Zhao L, Yuan M, Fu A. Identification and changes of different volatile compounds in meat of crucian carp under short-term starvation by GC-MS coupled with HS-SPME. Journal of Food Biochemistry 2017;41.
24. Hayashi S, Akiyama S, Tamaru Y, et al. A novel application of metabolomics in vertebrate development. Biochem Biophys Res Commun 2009;386:268-72.
25. Niu W, Knight E, Xia Q, McGarvey BD. Comparative evaluation of eight software programs for alignment of gas chromatography-mass spectrometry chromatograms in metabolomics experiments. J Chromatogr A 2014;1374:199-206.
26. Xia J, Wishart DS. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc 2011;6:743-60.
27. Durbin BP, Hardin JS, Hawkins DM, Rocke DM. A variance-stabilizing transformation for gene-expression microarray data. Bioinformatics 2002;18 Suppl 1:S105-10.
28. Dieterle F, Ross A, Schlotterbeck G, Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Analytical chemistry 2006;78:4281-90.
29. Filipiak W, Mochalski P, Filipiak A, et al. A compendium of volatile organic compounds (VOCs) released by human cell lines. Current medicinal chemistry 2016;23:2112-31.
30. Calenic B, Miricescu D, Greabu M, et al. Oxidative stress and volatile organic compounds: interplay in pulmonary, cardio-vascular, digestive tract systems and cancer. Open Chemistry 2015;13.
31. Bajtarevic A, Ager C, Pienz M, et al. Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 2009;9:348.
32. Bach Knudsen KE, Serena A, Canibe N, Juntunen KS. New insight into butyrate metabolism. Proc Nutr Soc 2003;62:81-6.
33. Sell DR, Strauch CM, Shen W, Monnier VM. Aging, diabetes, and renal failure catalyze the oxidation of lysyl residues to 2-aminoadipic acid in human skin collagen: evidence for metal-catalyzed oxidation mediated by alpha-dicarbonyls. Ann N Y Acad Sci 2008;1126:205-9.
34. Zajdel A, Wilczok A, Slowinski J, Orchel J, Mazurek U. Aldehydic lipid peroxidation products in human brain astrocytomas. J Neurooncol 2007;84:167-73.
35. Huang Z, Zhang J, Zhang P, Wang H, Pan Z, Wang L. Analysis of volatile organic compounds in pleural effusions by headspace solid-phase microextraction coupled with cryotrap gas chromatography and mass spectrometry. J Sep Sci 2016;39:2544-52.
36. Liu H, Li C, Wang H, et al. Characterization of Volatile Organic Metabolites in Lung Cancer Pleural Effusions by SPME–GC/MS Combined with an Untargeted Metabolomic Method. Chromatographia 2014;77:1379-86.
37. Wahl HG, Hoffmann A, Häring H-U, Liebich HM. Identification of plasticizers in medical products by a combined direct thermodesorption–cooled injection system and gas chromatography–mass spectrometry. Journal of Chromatography A 1999;847:1-7.
38. Szulejko JE, McCulloch M, Jackson J, McKee DL, Walker JC, Solouki T. Evidence for Cancer Biomarkers in Exhaled Breath. IEEE Sensors Journal 2010;10:185-210.
39. Meyer MR, Peters FT, Maurer HH. Automated mass spectral deconvolution and identification system for GC-MS screening for drugs, poisons, and metabolites in urine. Clin Chem 2010;56:575-84.
40. Styczynski MP, Moxley JF, Tong LV, Walther JL, Jensen KL, Stephanopoulos GN. Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. Analytical Chemistry 2007;79:966-73.
41. Lubes G, Goodarzi M. GC-MS based metabolomics used for the identification of cancer volatile organic compounds as biomarkers. J Pharm Biomed Anal 2018;147:313-22.
42. Richardson AD, Hollinger DY. A method to estimate the additional uncertainty in gap-filled NEE resulting from long gaps in the CO2 flux record. Agricultural and Forest Meteorology 2007;147:199-208.
43. Gharibvand L, Shavlik D, Ghamsary M, et al. The Association between Ambient Fine Particulate Air Pollution and Lung Cancer Incidence: Results from the AHSMOG-2 Study. Environ Health Perspect 2017;125:378-84.
44. Raaschou-Nielsen O, Andersen ZJ, Beelen R, et al. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol 2013;14:813-22.
45. Puett RC, Hart JE, Yanosky JD, et al. Particulate matter air pollution exposure, distance to road, and incident lung cancer in the nurses' health study cohort. Environ Health Perspect 2014;122:926-32.
46. Hystad P, Demers PA, Johnson KC, Carpiano RM, Brauer M. Long-term residential exposure to air pollution and lung cancer risk. Epidemiology 2013;24:762-72.
47. Cesaroni G, Badaloni C, Gariazzo C, et al. Long-term exposure to urban air pollution and mortality in a cohort of more than a million adults in Rome. Environmental health perspectives 2013;121:324-31.
48. Raaschou-Nielsen O, Andersen ZJ, Hvidberg M, et al. Lung cancer incidence and long-term exposure to air pollution from traffic. Environ Health Perspect 2011;119:860-5.
49. Beelen R, Hoek G, van den Brandt PA, et al. Long-term effects of traffic-related air pollution on mortality in a Dutch cohort (NLCS-AIR study). Environ Health Perspect 2008;116:196-202.
50. Beelen R, Hoek G, van den Brandt PA, et al. Long-term exposure to traffic-related air pollution and lung cancer risk. Epidemiology 2008;19:702-10.
51. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans Vsn-hpahasreL.
52. Angerer J, Ewers U, Wilhelm M. Human biomonitoring: state of the art. Int J Hyg Environ Health 2007;210:201-28.
53. Bostrom CE, Gerde P, Hanberg A, et al. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 2002;110 Suppl 3:451-88.
54. Bianchin JN, Nardini G, Merib J, Dias AN, Martendal E, Carasek E. Simultaneous determination of polycyclic aromatic hydrocarbons and benzene, toluene, ethylbenzene and xylene in water samples using a new sampling strategy combining different extraction modes and temperatures in a single extraction solid-phase microextraction-gas chromatography-mass spectrometry procedure. J Chromatogr A 2012;1233:22-9.
55. Bruce GR, Gill PS. Estimates of precision in a standard additions analysis. Journal of chemical education 1999;76:805.
56. Li W, Zhang J, Francis L. Handbook of LC-MS bioanalysis: best practices, experimental protocols, and regulations: John Wiley & Sons; 2013.
57. Sudakin DL, Stone DL, Power L. Naphthalene mothballs: emerging and recurring issues and their relevance to environmental health. Current topics in toxicology 2011;7:13.
58. Sutherland KD, Berns A. Cell of origin of lung cancer. Mol Oncol 2010;4:397-403.
59. Dybing E, Schwarze PE, Nafstad P, Victorin K, Penning TM. Polycyclic aromatic hydrocarbons in ambient air and cancer. Air Pollution and Cancer: International Agency for Research on Cancer, WHO Press Geneva; 2013.
60. Tang B, Isacsson U. Analysis of mono-and polycyclic aromatic hydrocarbons using solid-phase microextraction: state-of-the-art. Energy & Fuels 2008;22:1425-38.
61. Campo L, Fustinoni S, Consonni D, et al. Urinary carcinogenic 4-6 ring polycyclic aromatic hydrocarbons in coke oven workers and in subjects belonging to the general population: role of occupational and environmental exposure. Int J Hyg Environ Health 2014;217:231-8.
62. Moorthy B, Chu C, Carlin DJ. Polycyclic aromatic hydrocarbons: from metabolism to lung cancer. Toxicol Sci 2015;145:5-15.
63. Abdel-Shafy HI, Mansour MSM. A review on polycyclic aromatic hydrocarbons: Source, environmental impact, effect on human health and remediation. Egyptian Journal of Petroleum 2016;25:107-23.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/74821-
dc.description.abstract肺癌為癌症死因第一位,於不吸菸族群肺癌之發生率仍持續上升,推測與空氣汙染所致。肺癌致病機轉造成氧化壓力上升,產生揮發性有機化合物 (Volatile Organic Compounds, VOCs)並擴散至毛細微血管中。於先前研究用於新篩檢工具開發,發現以電子感應器陣列分析肺癌與對照組患者氣體,並利用機器學習建立預測肺癌模型驗證準確度為85.7%。然而呼氣分析仍可能含有其他如上皮、口腔細胞等其他VOCs之干擾,研究將分為二個目標: (1)分析肋膜積液之揮發性代謝物作為肺癌患者的生物標誌物,(2)使用肋膜積液作為暴露指標。以肺癌與非癌症病患的橫斷性研究設計,納入診斷為肺癌並接受胸水引流術之患者,與非惡性肋膜積液接受胸水引流術之患者,收集引流瓶中的肋膜積液,進行頂空分析,並以固相微萃取做為樣本前處理方法。分析內源性小分子VOCs選用CAR/PDMS纖維進行50℃頂空加熱,轉速800rpm,萃取10分鐘,再進行氣相層析質譜儀分析。共發現213個代謝物,基於偏最小平方判別分析(Partial least squares Discriminant Analysis, PLS-DA)中VIP(variable importance in the projection)值 > 1之代謝物,我們發現了78個代謝物,並使用這些高貢獻率的代謝物來構建PLS-DA,表現出很明顯的區分,置換測試顯示R2 = 0.79和Q2 = 0.65。此外,進一步進行了1000次重複的t檢驗。結果顯示,共49種代謝物的數據具有統計學意義(P <.05)。 PLS-DA也表現出明顯的區分,置換測試顯示R2 = 0.73和Q2 = 0.53。其中與肺癌機轉脂質過氧化相關之酮類包含methyl vinyl ketone, 4-amino-4-methyl-2-pentanone,甲基烷類包含1-methyl-2-propyl- cyclohexane, 1,1,2,2-tetramethyl-cyclopropane可能可視為生物指標。而空氣汙染相關之苯、甲苯、乙苯、二甲基苯以及多環芳香烴為待測物,並依據患者住家距離交通主要幹道來做族群分類。經固相微萃取最佳化條件後,使用PDMS/DVB纖維進行80℃加熱,轉速240rpm,萃取60分鐘,再進行氣相層析質譜儀分析。結果發現住家距離交通主要幹道小於300公尺的族群,Naphthalene與Fluoranthene濃度分別為0.57與0.30 ng/ml且顯著高於住家距離交通主要幹道大於300公尺的族群,由此推估肋膜積液可能可以成為空氣汙染暴露指標。將來,必須設計世代研究和確定暴露來源,以進一步探索暴露的空氣污染物與肺癌之間的相關性。zh_TW
dc.description.abstractLung cancer is the leading cause of cancer death, and the incidence of lung cancer in non-smoking populations is still rising. It was suspended to air pollution. Lung cancer pathogens cause an increase in oxidative stress, producing volatile organic compounds (VOCs). In the previous study was used sensor array to analysis exhaled air and building machine learning to early screening. The prediction accuracy of the predicted lung cancer model is 85.7%. However, breath analysis may still contain interference from other VOCs such as epithelial cells and oral cells. The study was be divided into two objectives: (1) To develop a screening test for lung cancer using a sensor array, (2) Use residential distance to major roadways to explore air pollution exposure. Designed for cross-sectional study of lung cancer and non-cancer patients receiving thoracentesis, collecting pleural effusion in drainage bottle and analysis by its head space. The analysis of solid phase microextraction (SPME) was used as a sample pretreatment method. The endogenous small molecule VOCs were analyzed by CAR/PDMS fiber for 50 °C headspace heating at 800 rpm for 10 min and analyzed. Based on the VIP score of the PLSDA model, we found 78 metabolites whose VIP scores were greater than 1. We used these metabolites that distributed were high contribution ratios to build PLS-DA. The PLS-DA also showed great discriminant and the permutation test showed the R2= 0.79 and Q2=0.65. Moreover, we conducted bootstrapping student's t-test with 1000 replications on these metabolites. The result showed that compared to the non-malignant patients, the data of 49 metabolites from the lung cancer patients were statistically significant (P < 0.05). The PLS-DA also showed great discriminant and the permutation test showed the R2= 0.73 and Q2=0.53. The ketones associated with lipid peroxidation of lung cancer include methyl vinyl ketone, 4-amino-4-methyl-2-pentanone, and methyl alkane contains 1-methyl-2-propyl-cyclohexane may be considered biomarkers. The air pollution-related benzene, toluene, ethylbenzene, dimethyl benzene and polycyclic aromatic hydrocarbons are the substances. After the SPME is optimized for extraction, the PDMS/DVB fiber is used for heating at 80℃, and the rotation speed is 240 rpm. , extraction for 60 min, and then analysis by its headspace. According to the residential distance from the main roadways to do group classification. The results showed that the concentration of naphthalene and fluoranthene was 0.57 and 0.30 ng/ml, respectively, which was significantly higher than that of the main road with residential distance of more than 300 meters. It is estimated that pleural effusion may be an indicator of air pollution exposure. In the future, the source of exposure and design cohort studies must be identified to further explore the correlation between exposed air pollutants and lung cancer.en
dc.description.provenanceMade available in DSpace on 2021-06-17T09:08:14Z (GMT). No. of bitstreams: 1
ntu-108-R05841019-1.pdf: 3176799 bytes, checksum: b09d77c75a1c8aa888800f3d0fd04d8a (MD5)
Previous issue date: 2019
en
dc.description.tableofcontents口試委員會審定書 i
中文摘要 ii
Abstracts iii
Chapter 1: To detect the volatile metabolites in pleural effusions as biomarkers for lung cancer patients 4
1.Introduction 4
2.Methods 5
2.1 Participants 5
2.2 Exclusion criteria 6
2.3 Medical, occupational and environmental history 6
2.4 Ultrasonic cleaning 6
2.5 Sample collection and preparation 7
2.6 Volatile metabolite analyses 7
2.7 Data preprocessing 8
2.8 Statistical analysis 9
3. Results 10
3.1 Optimization of SPME extraction conditions 10
3.2 Biomarker analysis 11
4. Discussion 12
5. Conclusion 15
Chapter 2: To determine pleural analysis can be used as an indicator of exposure 16
1. Introduction 16
2. Methods 17
2.1 Participants 17
2.2 Exclusion criteria 17
2.3 Medical, occupational and environmental history 18
2.4 Sample collection and preparation 18
2.5Volatile metabolite analyses 19
2.5.1 Instruments and standards Reagents and standards 19
2.5.2 Instrumental analysis 19
2.6 Quality assurance and quality control 20
2.7 Matrix effect 20
2.8 Method validation 21
2.9 Statistical analysis 22
2. Results 22
3.1 Experimental result - Quality assurance and quality control 22
3.2 Method validation 22
3.3 Analysis results 23
4. Discussion 23
5. Conclusion 25
Reference 26
Figure 33
Figure 1. Standardized procedures for the VOCs analysis 33
Figure 2. The standardized protocol for the GC-MS data processing in our study. 34
Figure 3. Flow diagram depicting the inclusion and exclusion of the study subjects. 35
Figure 4. PLS-DA plot of all metabolite 36
Figure 5. Permutation test of PLS-DA with all metabolite 37
Figure 6. PLS-DA 2D plot of VIP scores were greater than 1 38
Figure 7. Permutation test of PLS-DA with VIP scores were greater than 1 39
Figure 8. PLS-DA 2D plot of VIP scores were greater than 1 and bootstrapped student's t-test with 1000 replications were significant 40
Figure 9. Permutation test of PLS-DA with VIP scores were greater than 1 and bootstrapped student's t-test with 1000 replications were significant 41
Figure 10. The pathway analysis 42
Figure 11. Instrument blank to ensure there is no contamination in GC-MS system. 43
Figure 12. Reagent blank to ensure there is no contamination in the solvent. 43
Figure 13. The calibration curve of benzene with concentration ranged from 0.25-25 ng/ml 44
Figure 14. The calibration curve of toluene with concentration ranged from 0.1-25 ng/ml 44
Figure 15. The calibration curve of ethylbenzene with concentration ranged from 0.1-25 ng/ml 45
Figure 16. The calibration curve of m, p-xylene with concentration ranged from 0.1-10 ng/ml 45
Figure 17. The calibration curve of o-xylene with concentration ranged from 1-25 ng/ml 46
Figure 18. The calibration curve of naphthalene with concentration ranged from 0.1-25 ng/ml 46
Figure 19. The calibration curve of acenaphthylene with concentration ranged from 0.1-12.5 ng/ml 47
Figure 20. The calibration curve of acenaphthene with concentration ranged from 0.1-10 ng/ml 47
Figure 21. The calibration curve of fluorene with concentration ranged from 0.1-12.5 ng/ml 48
Figure 22. The calibration curve of phenanthrene with concentration ranged from 0.1-25 ng/ml 48
Figure 23. The calibration curve of anthracene with concentration ranged from 0.1-25 ng/ml 49
Figure 24. The calibration curve of fluoranthene with concentration ranged from 0.1-25 ng/ml 49
Figure 25. The calibration curve of pyrene with concentration ranged from 0.1-25 ng/ml 50
Figure 26. Flow diagram depicting the inclusion and exclusion of the study subjects. 51
Figure 27. The PCA biplot 52
Tables 53
Table 1. The parameters of MZmine 53
Table 2. Demographic characteristics of the study subjects 54
Table 3. Volatile compounds detected in the lung cancer patients and non-malignant patients under bootstrapped with t-test of p-value < 0.05 and VIP scores were greater than 1. 56
Table 4. Fisher exact test to the metabolites that had been delete because they had a non-zero value less than one out of four replicates in each of the lung cancer patients and non-malignant patients. 60
Table 5. List of retention times and identification ions for BTEX, PAH and the IS 63
Table 6. Demographic characteristics of the study subjects 66
Table 7. The geometric mean concentration of lung adenocarcinoma patients and non-malignant patients and p value 68
Table 8. The geometric mean concentration of the residential distance to main roadway and p-value 69
Appendix 70
Appendix I. The questionnaire of patients who had pleural effusion 70
Appendix II. Optimization of SPME extraction conditions 74
Appendix III. Comparison of VOCs found in pleural effusion. 75
Appendix IV. PLS-DA 2D plot of 58 metabolites whose VIP scores were greater than 1 and the fold change was <0.8 and >1.2. 92
Appendix V. Permutation test of PLS-DA with 58 metabolites whose VIP scores were greater than 1 and the fold change was <0.8 and >1.2. 93
Appendix VI. The 2,3-butanedione abundance of bar chart 94
Appendix VII. The results of gap-fiiling 95
dc.language.isoen
dc.title以氣體分析技術發展肺癌生物指標並探討肺癌與空氣汙染相關性研究zh_TW
dc.titleUse of gas analysis technology to develop volatile biomarkers for lung cancer and explore the association between lung cancer and air pollutionen
dc.typeThesis
dc.date.schoolyear108-1
dc.description.degree碩士
dc.contributor.coadvisor蔡詩偉(Shih-Wei Tsai)
dc.contributor.oralexamcommittee陳保中,賴錦皇
dc.subject.keyword代謝體,肺癌,生物指標,空氣汙染,感應器陣列,氣體分析,zh_TW
dc.subject.keywordMetabolites,lung cancer,biological indicators,air pollution,sensor arrays,gas analysis,en
dc.relation.page97
dc.identifier.doi10.6342/NTU201904295
dc.rights.note有償授權
dc.date.accepted2019-11-19
dc.contributor.author-college公共衛生學院zh_TW
dc.contributor.author-dept職業醫學與工業衛生研究所zh_TW
顯示於系所單位:職業醫學與工業衛生研究所

文件中的檔案:
檔案 大小格式 
ntu-108-1.pdf
  目前未授權公開取用
3.1 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved